Global Non-Invasive Prenatal Testing Market Size, Trend, Business Opportunities, Challenges, Drivers and Restraint Resea

Comments · 295 Views

Growth in the Non-Invasive Prenatal Testing (NIPT) industry is guided by the high probability of chromosomal anomalies with elevated maternal age, increased demand for non-invasive procedures over invasive approaches, enhanced NIPT reimbursement scenario and increased understanding of NIPT

The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research.The market intelligence report takes a closer view of the global market share, estimated growth rate, future market trends, entry-level barriers, fundamental market drivers, restraints, challenges, and opportunities. The report clearly defines the Global Non-Invasive Prenatal Testing market position on a global level. The detailed insights into the market’s geographical spectrum offered by the report make it an excellent source of knowledge about the Global Non-Invasive Prenatal Testing industry.The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies.

Browse Detailed Research report @https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Competitive Outlook:

The global Global Non-Invasive Prenatal Testing market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector.  The global Global Non-Invasive Prenatal Testing market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers acquisitions, new product launches, and joint ventures.NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

as well as new entrants in the market. It focuses on the recent mergers acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions, and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial status, and consumer base.

The report further segments the global Global Non-Invasive Prenatal Testing market on the basis of product types and applications and provides insights into key factors influencing the revenue growth of the segments.

 

The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report also offers a country wise analysis to impart better understanding of the global Global Non-Invasive Prenatal Testing market with regards to market share, market size, production and consumption ratio, product launches and RD activities, investment opportunities, and presence of key players in the region.

For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region:

  • Method Outlook (Revenue, USD Billion; 2017-2027)
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Cell-free DNA in Maternal Plasma Tests
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2017-2027)
    • Diagnostic Laboratories
    • Hospitals
    • Research Centers
    • Clinics
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Trisomy
    • Microdeletion Syndrome
    • Others

Get Free Sample PDF Brochure @https://www.emergenresearch.com/request-sample/16

Global Global Non-Invasive Prenatal Testing Market Report – Table of Contents:

  • Chapter 1 includes the global Global Non-Invasive Prenatal Testing market introduction, followed by the market scope, product offerings, growth opportunities, market risks, driving forces, and others.
  • Chapter 2 broadly categorizes the Global Non-Invasive Prenatal Testing market on the basis of geography, and determines the sales, revenue, and market shares of each region over the estimated period.
  • Chapter 3 elaborates on the competitive outlook of the Global Non-Invasive Prenatal Testing market, focusing on the major manufacturers and vendor landscape.
  • Chapter 4 exhaustively studies the key manufacturers of the Global Non-Invasive Prenatal Testing industry, along with their anticipated sales and revenue shares.
  • Chapters 5 includes market segmentation based on product type, application range, and market players.

The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.

Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

Regional Outlook of Global Non-Invasive Prenatal Testing Market:

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Click here to Get customization:https://www.emergenresearch.com/request-for-customization/16

Explore Similar Reports offered by Emergen Research:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

In-Vitro Fertilization Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Sports Medicine Market@ https://www.emergenresearch.com/industry-report/sports-medicine-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Comments